QA: Optinose Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001494650_2022_Optinose_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001494650, Optinose Inc

  xvar xval
0 AssetsCurrent 160,379,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,347,000
3 remainder_Assets 4,345,000
4 LiabilitiesCurrent 59,235,000
5 LiabilitiesNoncurrent 128,608,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 14,094,104
8 SellingGeneralAndAdministrativeExpense 107,792,139
9 ResearchAndDevelopmentExpense 24,824,360
10 remainder_Expenses 17,079,867
11 remainder_Revenues 189,639,865
12 remainder_NetIncome 217,153
13 remainder_ComprehensiveNetIncome -36,847
  yvar yval
0 Assets 166,071,000
1 Liabilities 187,843,000
2 Expenses 163,790,470
3 Revenues 189,639,865
4 StockholdersEquity -21,772,000
5 NetIncome 26,066,548
6 ComprehensiveNetIncome 26,048,124
7 BaseVar 353,799,168
8 EconomicCapitalRatiobeforeLimitedLiability -0.121
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time